- ADMINISTRATIVE CORE The Administrative Core of the Mayo Alzheimer's Disease Research Center (ADRC) will coordinate the overall research activities of the Center at both sites in Rochester, Minnesota, and Jacksonville, Florida. The Core will oversee the integration of the research activities of the Center in pursuing the Specific Aims. The Core will interact with program officials at the National Institute on Aging and will be responsible for personnel and financial matters. The Core will also coordinate data transfer and communications with the National Alzheimer's Coordinating Center. The Mayo ADRC has an active Pilot Project Program, and the Core will solicit applications, review them and communicate with the National Institute on Aging on selected pilot projects. The Core will also convene the External Advisory Committee for the Mayo ADRC and hold annual meetings. The Internal Steering Committee of the ADRC will be coordinated by the Administrative Core, and monthly videoconferences will be held between Rochester and Jacksonville. The Core will also oversee the activities of the three research projects and support their research missions. Ultimately, the Administrative Core will be responsible for maintaining research along the themes of the ADRC: 1) to evaluate subjects along the AD spectrum and 2) to support research projects for AD-related dementias.
- ADMINISTRATIVE CORE Alzheimer's disease is a complex condition affecting tens of millions of people worldwide. The Mayo Alzheimer's Disease Research Center is focusing much of its effort on understanding the basis for the disease, improving diagnoses, monitoring biomarkers and exploring new potential treatments. The Administrative Core is an essential element in the Center and is responsible for coordinating the activities of the cores and projects as well as communicating with the National Institute on Aging and other Alzheimer's centers. The Core is ultimately responsible for all the research conducted in the Center.
|Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717|
|Ma, Li; Allen, Mariet; Sakae, Nobutaka et al. (2016) Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains. Mol Neurodegener 11:72|
|Tosto, Giuseppe; Bird, Thomas D; Bennett, David A et al. (2016) The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol 73:1231-1237|
|Zheng, Honghua; Liu, Chia-Chen; Atagi, Yuka et al. (2016) Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging 42:132-41|
|Staubo, Sara C; Aakre, Jeremiah A; Vemuri, Prashanthi et al. (2016) Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement :|
|Kantarci, Kejal; Lowe, Val J; Lesnick, Timothy G et al. (2016) Early Postmenopausal Transdermal 17Î²-Estradiol Therapy and Amyloid-Î² Deposition. J Alzheimers Dis 53:547-56|
|McCutcheon, Sarah T; Han, Dingfen; Troncoso, Juan et al. (2016) Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. Int J Geriatr Psychiatry 31:1301-1311|
|Forrester, Sarah N; Gallo, Joseph J; Smith, Gwenn S et al. (2016) Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. Am J Geriatr Psychiatry 24:117-25|
|LabbÃ©, Catherine; Heckman, Michael G; Lorenzo-Betancor, Oswaldo et al. (2016) MAPT haplotype diversity in multiple system atrophy. Parkinsonism Relat Disord 30:40-5|
|Nicholson, Alexandra M; Finch, NiCole A; Almeida, Marcio et al. (2016) Prosaposin is a regulator of progranulin levels and oligomerization. Nat Commun 7:11992|
Showing the most recent 10 out of 813 publications